News and press releases

Cancel
  • Standing next to scientist Andreas Körtge with a bouquet of flowers and certificate is Reinhard Meyer, Minister of Economic Affairs of Mecklenburg-Vorpommern.
    © BioCon Valley® GmbH / Danny Gohlke

    On 2 May 2024, Reinhard Meyer, minister for economic affairs of Mecklenburg-Vorpommern, presented the awards to the winners of the “Innovative ideas for the healthcare sector” competition, in the state’s capital, Schwerin. The seven winners included a project proposal by Fraunhofer IZI’s Rostock Department of Extracorporeal Therapy. The successful project was “mi4ASSESS-MED – A marketing and innovation strategy to strengthen the market position and competitiveness of ASSESS-MED”.

    more info
  • CAR-T cell therapy has been established as an effective treatment for various haematological cancers. However, the treatment does not have the same level of success in all patients. In a current clinical study, researchers from the University of Leipzig Medical Center and the Fraunhofer Institute for Cell Therapy and Immunology IZI have identified various biomarkers which are linked to the response to CAR-T cell therapy in multiple myeloma, a type of bone marrow cancer. The results of their study were published in the renowned journal Nature Cancer.

    more info
  • Scientist in a white coat in the lab
    © Fraunhofer IZI

    In her doctoral thesis, Dr. Susann Allelein from the Fraunhofer Institute for Cell Therapy and Immunology IZI investigated a new approach for the early detection of prostate cancer in particular. She was awarded the 3rd Hugo Geiger Prize 2023 on February 28, 2024. The prize, awarded by the Free State of Bavaria and the Fraunhofer-Gesellschaft, recognizes outstanding, application-oriented doctoral theses.

    more info
  • © Leibniz University Hannover, Germany

    What influence do changes in land use and a loss of biodiversity have on the transmission of pathogens between animals and humans? This question is being investigated by an international and interdisciplinary research team as part of the EU project ZOE - "Zoonosis Emergence accros Degraded and Restored Forest Ecosystems". Partners from seven European and four American countries are participating in the project, which is led by Charité - Universitätsmedizin Berlin. The Fraunhofer Institute for Cell Therapy and Immunology IZI is contributing its expertise in the field of virology and assay development.

    more info
  • An international team started the research project CERTAINTY in December 2023. Together with partners from science, industry and the healthcare sector, the project team led by the Fraunhofer Institute for Cell Therapy and Immunology IZI aims to develop a virtual twin that will improve treatment with personalized cancer immunotherapies in the future.

    more info
  • Holger Cynis
    © Fraunhofer IZI

    Deputy Head of the Fraunhofer IZI Department of Drug Design and Target Validation Dr. Holger Cynis has been appointed Junior Professor for "Immunomodulation in Pathophysiological Processes" at the Medical Faculty of Martin Luther University Halle-Wittenberg (MLU), effective November 1, 2023. Jun.-Prof. Dr. Holger Cynis researches how certain mechanisms of the immune system can trigger diseases, with the aim of developing novel active substances.

    more info
  • Keshia Aerchlimann in the lab.
    © Fraunhofer IZI

    A doctoral scholarship from the Deutsche José Carreras Leukämie-Stiftung for Keshia Aerchlimann (Fraunhofer Institute for Cell Therapy and Immunology) supports the development of an organ-on-a-chip model for the cultivation and investigation of leukemia cells.

    more info
  • A new research center, CREATIC, has been launched at Masaryk University's Faculty of Medicine. Here, ATMPs are to be developed for the treatment of rare life-threatening or chronic diseases that are currently considered incurable. Fraunhofer IZI contributes its expertise in the development and production of gene and cell therapies in an advisory capacity and is involved in pilot projects within CREATIC. The project is funded by the European Commission as part of the Horizon Europe Teaming for Excellence program with 15 million euros over the next six years.

    more info